New medicines from the category of monoclonal virus-neutralizing antibodies have started to be utilized in Moscow hospitals; such treatments are used all over the globe to treat patients at an early point of coronavirus development, according to the Moscow headquarters, quoting deputy mayor Anastasia Rakova.
First and foremost, such treatment is advised for pregnant women with coronavirus who are at risk of developing a severe case of the illness, Vedomosti writes. Short-term hospitals are located at Hospital No. 15 called O. M. Filatov and Hospital No. 52, where women’s health is supervised by obstetricians-gynecologists.
“According to the medical commission’s decision for the treatment of women with COVID-19 during pregnancy, medicines from the category of monoclonal virus-neutralizing antibodies may be used for antiviral therapy. More than 70 patients in Moscow have undergone this treatment to far,” Rakova added.
According to her, no adverse effects occurred in the patients, but there was a fast elimination of the virus and a betterment in their health. This treatment is currently being utilized in the United States, France, Germany, Italy, and other nations.
Doctors believe that pregnant women are more vulnerable to respiratory illnesses owing to physiological changes in the immunological and cardiovascular systems, putting them at risk for a severe coronavirus course.
The US Food and Drug Administration approved the emergency use of recombinant monoclonal antibodies for the treating of coronavirus in adults and adolescents in May of this year. A favorable scientific opinion has also been given by the EU authority. The Russian Ministry of Health granted permission for such medicines to be temporarily circulated and imported into the nation.
